secwatch.observer — SEC 8-K summary
======================================

Issuer:     Finch Therapeutics Group, Inc. (FNCHQ)
CIK:        0001733257
Form:       8-K
Filed at:   2021-09-13T23:59:59+00:00
Accession:  0001564590-21-047668
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Finch Therapeutics posts updated corporate presentation on website
------------------------------------------------------------------

- Presentation dated September 2021 titled 'Harnessing the Genomic Revolution & Machine Learning to Pioneer Microbiome Therapeutics'.
- Available under 'Events & Presentations' in the Investors section of the company's website.
- No specific financial or pipeline updates were disclosed in the filing; content of the slide deck is not summarized.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1733257/000156459021047668/0001564590-21-047668-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1733257/000156459021047668/fnch-8k_20210913.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-047668

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer